期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | NEUROLOGY INDIA LetPub Score 4.8
50 ratings
Rate
Reputation 5.5 Influence 3.7 Speed 6.9 | ||||||||||||||||||||
期刊簡稱 | NEUROL INDIA | ||||||||||||||||||||
ISSN | 0028-3886 | ||||||||||||||||||||
E-ISSN | 1998-4022 | ||||||||||||||||||||
h-index | 43 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 11.10%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://www.neurologyindia.com/ | ||||||||||||||||||||
在線稿件提交 | http://www.neurologyindia.com/submitarticle.asp | ||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||
出版商 | Wolters Kluwer Medknow Publications | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | INDIA | ||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||
創刊年 | 1964 | ||||||||||||||||||||
每年文章數 | 159每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 0.00% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q4
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0028-3886%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 2 Month(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: About 80% | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[NEUROLOGY INDIA] 的評論 | 撰寫評論 |
作者: Doctor wang 領域: 医学 審稿時間: 8.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-19 23:05:32 評論於 I am the OP, it has been over a month now, still with editor, don't know what this editor is doing, so busy??? Or intentional, a small fix can be dragged for over a month, what are you waiting for??? Really far-fetched!!!!(0) 讚! | Doctor wang |
作者: Doctor wang 領域: 医学 審稿時間: 8.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-19 21:54:32 評論於 It has been 18 days since I submitted the manuscript for revisions, and it is still with the editor. I wonder how long I will have to wait(1) 讚! | Doctor wang |
作者: 令璟大叔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-31 19:57:47 評論於 How did you handle it afterwards?(0) 讚! | 令璟大叔 |
作者: 令璟大叔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-31 14:17:12 評論於 Research focus: cerebrovascular diseases; Clinical experience sharing: submitted a case, editor invited 2 months ago, what is going on, sent 2 follow-up emails but no response(0) 讚! | 令璟大叔 |
作者: 碧水芙蓉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-29 10:41:15 評論於 How much is the layout fee for this magazine?(0) 讚! | 碧水芙蓉 |
作者: 缠丝代梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-19 18:46:54 評論於 Have you submitted? How fast is the review process?(0) 讚! | 缠丝代梅 |
作者: 是你的柯豪呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-23 22:55:24 評論於 Research focus: Cerebrovascular; Pure Data Science experience sharing: Are articles from Pure Data Science easy to submit?(0) 讚! | 是你的柯豪呀 |
作者: 深渊婉淑 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-07 20:43:48 評論於 I also had to search for a long time to find it, you can find the download in the submission system, and you also need to sign it by hand(0) 讚! | 深渊婉淑 |
作者: 墨彻小娘子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-07 14:33:09 評論於 Where can I find the Copyright Transfer Form for this magazine? Could you send me a copy? Thank you very much(0) 讚! | 墨彻小娘子 |
作者: 墨彻小娘子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-06 22:41:49 評論於 Where can I find its Copyright Transfer Form?(0) 讚! | 墨彻小娘子 |
作者: 秀艳小可爱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-12 20:41:39 評論於 Review speed: 6.0 | Submission hit rate: 75.0 Research focus: Spinal surgery; Neurosurgery Experience sharing: Submitted on January 27, 2022, returned due to formatting issues on January 29, fixed and resubmitted on the same day. Technical modifications on February 8, accepted on June 9, proofread on June 22, and will be published online on November 11(0) 讚! | 秀艳小可爱 |
作者: 秀艳小可爱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-11 20:23:20 評論於 Review speed: 6.0 | Submission hit rate: 75.0 Emphasized research direction: Spinal surgery; Neurosurgery Experience sharing: Submitted on 2022.01.27, rejected for format issues on 2022.01.29, revised and resubmitted on the same day Technical modification on 2022.02.08 Accepted on 2022.06.09 Proof on 2022.06.22 Online on 2022.11.11 Overall, not difficult, but the review process feels slow, and it feels a bit slow after proofing. Suitable for submitting articles that are not urgent(0) 讚! | 秀艳小可爱 |
作者: 倩语小郎君 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-11 13:01:21 評論於 Revised once, it has been two months but still no decision has been made(0) 讚! | 倩语小郎君 |
作者: 一条小痴云 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-30 11:48:20 評論於 Review speed: 12.0 | Submission acceptance rate: 50.0 Emphasized research direction: Clinical neurology Experience sharing: Currently very slow, review speed takes more than half a year(0) 讚! | 一条小痴云 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 18:33:03 評論於 When explaining your innovative points, it is important to focus on the shortcomings of previous research in order to describe your solution approach clearly and completely. Innovation requires the use of introductory techniques to highlight more content that benefits oneself. To highlight the innovation of this study, it is necessary to select from many citations the points that highlight the differences and characteristics of this study, such as: (1) issues related to time; (2) issues related to research methods; (3) issues related to research areas; (4) uncertainty; (5) proposing one's own hypotheses for verification(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 17:05:41 評論於 There is usually no word limit, but it should take up a certain proportion(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 平原文波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 22:37:13 評論於 How many words should generally be written in the introduction?(0) 讚! | 平原文波 |
作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 10:21:51 評論於 How is the innovativeness of the article reflected in the introduction?(0) 讚! | Oswald Edie |
作者: 天霜初瑶 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-26 09:21:36 評論於 Review Speed: 24.0 | Submission Success Rate: 75.0 Research focus: Neurosurgery Experience sharing: Submitted another low-quality clinical study, requested revision after 364 days, accepted after 672 days, published after over 880 days, what a huge pit. The only good thing is the low expectations, but don't submit unless you have nothing better to do(0) 讚! | 天霜初瑶 |
作者: Vera Terry 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-10-10 23:18:42 評論於 Terrible attitude, it's been two months and they are still editing the comments. I have sent numerous emails, but haven't received a single reply. It may be related to the poor India-China relations or the COVID-19 situation in India(0) 讚! | Vera Terry |
作者: Broderick Malthus 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-05-28 22:11:44 評論於 No reviewers invited. What should I do about this? What does this mean?(0) 讚! | Broderick Malthus |
作者: 先天帅红 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-04-30 17:41:32 評論於 How many days did it take for your revision to be accepted for pre-acceptance?(0) 讚! | 先天帅红 |
作者: 华清丙辰 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-12-06 11:21:00 評論於 I submitted my application in mid-April 2018 and have sent emails to inquire about the progress, but I still haven't received any updates. It has been 8 months and I am in urgent need of a response as I need to graduate(0) 讚! | 华清丙辰 |
作者: 静心癸丑 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-03-21 17:15:20 評論於 Review speed: 6.0 | Submission hit rate: 50.0 Experience sharing: Submitted a case report, low quality, requested to change to letter to the editor. Accepted after revision, takes around 6 months(0) 讚! | 静心癸丑 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 09:43:18 評論於 From below 1.5 points, it is now close to 2 points, which is a good sign. This magazine is worth owning(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us